{"denoms":[{"counts":[{"groupId":"BG000","value":"12"}],"units":"Participants"}],"groups":[{"description":"Testosterone USP micronized powder supplied by Medisca Pharmacy will be compounded by Precision Compounding pharmacy as testosterone 0.3% per 0.5 milliliters (mL) in pharmabase cream. The compounded testosterone vaginal cream will be supplied in pre-filled syringes and each 0.5 mL dose will deliver 300 mcg of testosterone daily. The cream will be applied to the vaginal opening once daily for four weeks (28 days).","id":"BG000","title":"Vaginal Testosterone"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"6.095","value":"59.67"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"Married"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"Not Married"}],"paramType":"NUMBER","title":"Marital Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"0-5 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"6-10 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"11-15 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"16-20 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"21-25 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"26-30 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"31-35 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"36-40 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"41-50 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"51-55 years"}],"paramType":"NUMBER","title":"Length of Marriage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"High school degree"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Associate's degree"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Bachelor's degree"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Master's degree"}],"paramType":"NUMBER","title":"Highest Level of Education","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"No"}],"paramType":"NUMBER","title":"Oophorectomy","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"ER+"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"ER-"}],"paramType":"NUMBER","title":"Estrogen-receptor (ER) Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"PR+"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"PR-"}],"paramType":"NUMBER","title":"Progesterone-receptor (PR) Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"HER2+"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"HER2-"}],"paramType":"NUMBER","title":"Human Epidermal Growth Factor Receptor 2 (HER2) Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"anastrozole (Arimidex)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"letrozole (Femara)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"exemestane (Aromasin)"}],"paramType":"NUMBER","title":"Aromatase Inhibitor","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"No vaginal infection"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Gardnerella vaginalis"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"Candidiasis species"}],"description":"A vaginal swab was obtained prior to prescribing testosterone therapy because women with suppressed estrogen levels have an increased risk of infection.","paramType":"NUMBER","title":"Vaginal Swab Test","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"No"}],"paramType":"NUMBER","title":"Sexually Active Prior to Study","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"No"}],"paramType":"NUMBER","title":"Sexually Active During Study","unitOfMeasure":"Participants"}],"populationDescription":"One patient withdrew due to symptoms of recurrent Gardnerella vaginalis."}